RRML - The role of cytokines, cytogenetic factors and oncogenes in the prognosis of multiple myeloma
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- May 2021 -
 
Prognostic value of serum lact... 9
Vaginal candidiasis in Konya a... 5
Romanian Review of Laboratory ... 4
Prevalence of ∆F508 cystic f... 4
Polymorphisms in autophagy gen... 3
Rapid loss of HBs antigen in p... 3
Reliability of Friedewald form... 3
Frequency, Distribution and Ge... 3
Predictors associated with inc... 3
Pseudohyponatremia and falsely... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 15(2)/2009
XML
TXT

The role of cytokines, cytogenetic factors and oncogenes in the prognosis of multiple myeloma

Gabriel Dragoş I. Găman, Amelia Maria V. Găman


Abstract:

A series of cytokines, like IL-3, IL-5, IL-6, IL-10, M oncostatin, ILGF1, stimulate the growth of myelomatous cells. Some of them can worsen the prognosis of patients with multiple myeloma through their negative effects (osteolysis, inhibition of erythropoiesis) or may induce benefic effects (megakariopoiesis stimulation). The presence of chromosomal abnormalities might add to a positive prognosis (hyperdiploidia of 3, 5, 7, 9, 11, 15, 19, 21) or, conversely, could be a bad prognostic factor: t(4;14), t(14;16), del 13q and 17p13. The study of gene expression in multiple myeloma represents a modern method of identifying the genes which, through their overexpression, aggravate the patients prognosis. Until now, approximately 33000 types of these genes have been studied in multiple myeloma.

Keywords: multiple myeloma,cytokines,chromosomial abnormalities,oncogenes,prognosis.

 
  PDF Download full text PDF
(66 KB)
     
 
How to cite
Găman GDI, Găman AMV. The role of cytokines, cytogenetic factors and oncogenes in the prognosis of multiple myeloma. Rev Romana Med Lab. 2009;15(2):27-32